• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增生异常综合征患者在接受周期性粒细胞-巨噬细胞集落刺激因子治疗期间反复出现脾脏肿大。

Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome.

作者信息

Delmer A, Karmochkine M, Cadiou M, Gerhartz H, Zittoun R

机构信息

Service d'Hématologie, Hôtel-Dieu, Paris, France.

出版信息

Am J Hematol. 1990 May;34(1):73-4. doi: 10.1002/ajh.2830340117.

DOI:10.1002/ajh.2830340117
PMID:2183595
Abstract

A 65-year-old woman with refractory anemia with excess of blasts received sequential courses of granulocyte-macrophage colony-stimulating factor therapy (GM-CSF) and low-dose cytosine arabinoside. Each course of GM-CSF induced a rapid and tremendous increase in leukocyte count as well as in spleen size, 111indium chloride scanning suggested a myeloid metaplasia of the spleen. This observation suggests that in some patients the granulopoietic response to the myeloid growth factor stimulation may be predominant in the spleen.

摘要

一名65岁患有原始细胞过多的难治性贫血女性接受了粒细胞-巨噬细胞集落刺激因子疗法(GM-CSF)和小剂量阿糖胞苷的序贯疗程。GM-CSF的每个疗程均导致白细胞计数以及脾脏大小迅速大幅增加,氯化铟扫描提示脾脏存在髓外化生。这一观察结果表明,在某些患者中,脾脏对髓系生长因子刺激的粒细胞生成反应可能占主导。

相似文献

1
Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome.骨髓增生异常综合征患者在接受周期性粒细胞-巨噬细胞集落刺激因子治疗期间反复出现脾脏肿大。
Am J Hematol. 1990 May;34(1):73-4. doi: 10.1002/ajh.2830340117.
2
Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes.
Haematol Blood Transfus. 1990;33:763-9. doi: 10.1007/978-3-642-74643-7_138.
3
Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.骨髓增生异常综合征患者皮下注射粒细胞-巨噬细胞集落刺激因子:毒性、药代动力学及血液学效应
J Clin Oncol. 1989 May;7(5):629-37. doi: 10.1200/JCO.1989.7.5.629.
4
Clinical applications of colony-stimulating factors.
Semin Oncol. 1988 Dec;15(6 Suppl 6):27-33.
5
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.重组人粒细胞巨噬细胞集落刺激因子治疗再生障碍性贫血和骨髓增生异常综合征的I/II期研究
Blood. 1988 Aug;72(2):705-13.
6
Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.粒细胞巨噬细胞集落刺激因子增强阿糖胞苷对急性髓细胞白血病及慢性髓细胞白血病髓系原始细胞危象期的细胞毒性作用。
Leukemia. 1989 May;3(5):328-34.
7
Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
Behring Inst Mitt. 1988 Aug(83):134-8.
8
Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.粒细胞巨噬细胞集落刺激因子可扩大人体循环造血祖细胞池。
Lancet. 1988 May 28;1(8596):1194-8. doi: 10.1016/s0140-6736(88)92012-0.
9
Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.粒细胞巨噬细胞集落刺激因子在恶性肿瘤和骨髓衰竭患者中的应用。
Int J Cell Cloning. 1990 Jan;8 Suppl 1:303-12; discussion 312-3. doi: 10.1002/stem.5530080729.
10
Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.重组人粒细胞巨噬细胞集落刺激因子用于骨髓增生异常综合征患者——一项I/II期试验
Blood. 1989 Jan;73(1):31-7.

引用本文的文献

1
Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression.通过慢病毒载体介导的蛋白质表达纠正慢性肺部疾病。
Mol Ther Methods Clin Dev. 2022 Apr 14;25:382-391. doi: 10.1016/j.omtm.2022.04.002. eCollection 2022 Jun 9.
2
Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease.粒细胞-巨噬细胞集落刺激因子 mRNA 与帕金森病的神经保护免疫。
Biomaterials. 2021 May;272:120786. doi: 10.1016/j.biomaterials.2021.120786. Epub 2021 Mar 31.
3
Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice.
长效粒细胞-巨噬细胞集落刺激因子(mPDM608)在 1-甲基-4-苯基-1,2,3,6-四氢吡啶中毒小鼠中的神经保护活性。
Neurotherapeutics. 2020 Oct;17(4):1861-1877. doi: 10.1007/s13311-020-00877-8.
4
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.重组粒细胞-巨噬细胞集落刺激因子(rGM-CSF):其药理特性及在骨髓抑制管理中的潜在作用综述
Drugs. 1992 Apr;43(4):516-560. doi: 10.2165/00003495-199243040-00008.
5
Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group.低剂量阿糖胞苷(LD-AraC)联合粒细胞-巨噬细胞集落刺激因子(rh GM-CSF)治疗骨髓增生异常综合征(MDS)及高白血病风险患者。欧洲癌症研究与治疗组织白血病研究组。
Infection. 1992;20 Suppl 2:S116-23. doi: 10.1007/BF01705030.